|
|
Home
> CSL Behring - USA Homepage
We are passionate about improving the quality of life for patients with hemophilia, immune deficiency disorders and Alpha-1 antitrypsin (AAT) deficiency. Our life-saving therapies help prevent blood-related diseases in newborns and are used in trauma and surgical care.
19 August 2008Voluntary Withdrawal of Monoclate-P® Initiated
18 August 2008CSL Behring Funds Study of Postpartum Women with VWD
|